These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 18536169

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.
    Biava M, Porretta GC, Poce G, De Logu A, Meleddu R, De Rossi E, Manetti F, Botta M.
    Eur J Med Chem; 2009 Nov; 44(11):4734-8. PubMed ID: 19595488
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel dihydropyrimidines as a potential new class of antitubercular agents.
    Trivedi AR, Bhuva VR, Dholariya BH, Dodiya DK, Kataria VB, Shah VH.
    Bioorg Med Chem Lett; 2010 Oct 15; 20(20):6100-2. PubMed ID: 20813528
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D, Manetti F, Radi M, Bechi B, Pagano M, De Logu A, Meleddu R, Saddi M, Botta M.
    Bioorg Med Chem; 2009 Aug 01; 17(15):5716-21. PubMed ID: 19581099
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
    Sriram D, Yogeeswari P, Madhu K.
    Bioorg Med Chem Lett; 2005 Oct 15; 15(20):4502-5. PubMed ID: 16115763
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.
    Sinha N, Jain S, Tilekar A, Upadhayaya RS, Kishore N, Jana GH, Arora SK.
    Bioorg Med Chem Lett; 2005 Mar 15; 15(6):1573-6. PubMed ID: 15745799
    [Abstract] [Full Text] [Related]

  • 16. Antituberculosis agents. III. In vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives.
    Foroumadi A, Soltani F, Emami S, Davood A.
    Boll Chim Farm; 2002 Mar 15; 141(3):247-9. PubMed ID: 12197426
    [Abstract] [Full Text] [Related]

  • 17. Increment of antimycobaterial activity on lichexanthone derivatives.
    Micheletti AC, Honda NK, Pavan FR, Leite CQ, Matos Mde F, Perdomo RT, Bogo D, Alcantara GB, Beatriz A.
    Med Chem; 2013 Nov 15; 9(7):904-10. PubMed ID: 23106287
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
    Sriram D, Senthilkumar P, Dinakaran M, Yogeeswari P, China A, Nagaraja V.
    J Med Chem; 2007 Nov 29; 50(24):6232-9. PubMed ID: 17960928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.